At a news conference earlier on Wednesday, Ms Kyriakides said
UK factories, which have not experienced problems, were part of its deal with the company and had to deliver.
In an interview on Tuesday with Italian newspaper La Repubblica, AstraZeneca CEO Pascal Soriot said the contract compelled it to make its "best effort", rather than obliging it to meet a set deadline for delivery of the vaccines.
Ms Kyriakides said
this characterisation of the deal was "not correct or acceptable", and called on the company to be "open and transparent" about its production of vaccines.
[...]
The EU reiterated its position
after the two sides met on Wednesday evening to try to resolve the issue.
[...]
In a nutshell, here is why EU officials are furious with AstraZeneca.
They say the contract between them and the pharmaceutical giant clearly stipulates that the two main vaccine production factories in the UK are to be classed as primary manufacturing sites, and the production sites in Belgium and the Netherlands are secondary priorities.
The vaccine production issues are in Belgium and the Netherlands (they have been producing lower yields). So, this is a no-brainer to EU officials - the UK sites should be used to transport the vaccines across the continent.
[...]
In fact, EU officials point out to me that EU money went into upgrading the facilities in the UK and that they fully expected it to be operational for them.